CompletedN/Aketamine

Stanford Regulating Circuits of the Brain Study- Ketamine

Sponsored by Stanford University

NCT ID
NCT03475277
Target Enrollment
13 participants
Start Date
2019-08-19
Est. Completion
2024-07-01

About This Study

This study is a biomarker study designed to characterize how ketamine impacts the reward circuits of the human brain.

Conditions Studied

Healthy

Interventions

  • Ketamine

Eligibility

Age:18 Years - 55 Years
View full eligibility criteria
Inclusion Criteria:

* Ages 18-55 years
* At least 2 prior uses of ketamine when aged 18+
* BMI within healthy range (18-30)
* Ability to speak, read, or understand English

Exclusion Criteria:

* Current active suicide ideation or history of suicide attempts
* Current mood, anxiety, eating, psychotic, or substance use disorder
* Lifetime psychotic or bipolar disorder
* Schizophrenia in a first degree relative
* Current use of psychotropic medication
* Prior adverse ketamine response
* Allergy or hypersensitivity to ketamine
* Use of ketamine in past 7 days
* Cannabis use in the past 7 days, illicit recreational drug use in the 48 hours prior to sessions, and/or alcohol use in the 24 hours prior to sessions
* Concurrent use of any medications that might increase the risk of participation (e.g., drug interactions)
* History of epilepsy, convulsions, seizures, LOC \>10 min
* Renal/hepatic impairment
* Hypertension (Stage 1 defined as systolic blood pressure \>140 mmHg or diastolic blood pressure \>90 mmHg on 2 of 3 measurements at least 15 min apart at initial screening; systolic blood pressure \>155 mmHg or diastolic blood pressure \>99 mmHg on 2 of 3 measurements at least 15 min apart during infusion visits)
* Heart rate \<50 bpm or \>150 bpm at initial screening
* Chronic congestive heart failure, tachyarrhythmias, myocardial ischemia assessed via EKG at initial screening
* EKG QTcF intervals \>430 ms for men and \>470 ms for women
* Direct physical access to or routine handling of addicting drugs in the regular course of work duties
* MRI contraindication
* Pregnant or nursing females

Study Locations (1)

Stanford Psychiatry
Palo Alto, California, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source